Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?

This study has been completed.
Sponsor:
Information provided by:
Scranton-Temple Residency Program
ClinicalTrials.gov Identifier:
NCT00984841
First received: September 24, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
  Purpose

The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.


Condition Intervention
Diabetes Mellitus
Other: Tailored letter

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?"

Resource links provided by NLM:


Further study details as provided by Scranton-Temple Residency Program:

Primary Outcome Measures:
  • Diabetes summary quality measure [ Time Frame: 4 months ] [ Designated as safety issue: No ]

Enrollment: 467
Study Start Date: January 2009
Study Completion Date: July 2009
Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Tailored letter
Patients in the tailored letter group received by mail a tailored letter detailing their diabetes measures, together with enclosed orders for lab tests when due, and reminder of or scheduling for an office appointment.
Other: Tailored letter
Active Comparator: Usual Care
Patients in the usual care group were part of a practice wide quality improvement process.
Other: Tailored letter

Detailed Description:

Diabetes care in the US is less than optimal. Some authors have found that targeted patient letters are also an effective tool to improve outcomes when they are part of a comprehensive disease management plan. Local patient satisfaction surveys had revealed that many patients had sub‐optimal understanding of diabetes measures and of the importance of controlling these measures to reduce diabetic complications. We wondered if tailored patient letters and enclosed lab orders when due might increase patient awareness of diabetes measures and increase patient engagement.We hypothesized that the addition of targeted patient letters with enclosed lab orders to an ongoing performance improvement program would further improve diabetes care.

We conducted a randomized controlled study of tailored patient letters and diabetes lab orders at our two resident‐based clinics.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All active patients age 18 to 75 years with a diagnosis of diabetes mellitus were eligible.
  • An active patient was defined as one having an ICD‐9 code on the active problem list identifying the patient as diabetic, and a progress note in the EMR associated with an office visit within the prior 12 months.

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00984841

Locations
United States, Pennsylvania
Scranton-Temple Health Center
Scranton, Pennsylvania, United States, 18510
Sponsors and Collaborators
Scranton-Temple Residency Program
Investigators
Principal Investigator: John R Guzek, MD Scranton-Temple Residency Program
  More Information

No publications provided

Responsible Party: John R Guzek, MD, Scranton-Temple Residency Program
ClinicalTrials.gov Identifier: NCT00984841     History of Changes
Other Study ID Numbers: STRP001
Study First Received: September 24, 2009
Last Updated: September 24, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Scranton-Temple Residency Program:
Diabetes Mellitus targeted mailing

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 20, 2014